Despite evidence that pharmacists enhance patient outcomes in kidney disease management and guidelines promoting multidisciplinary care, the extent of pharmacist training in nephrology remains poorly defined. This study aims to examine both required and elective coursework related to kidney diseases in Doctor of Pharmacy programs across the United States. The findings will help identify educational gaps and inform the development of best practices for pharmacist training in the care of patients with kidney diseases.This study employed a prospective, cross-sectional, descriptive design to evaluate current educational practices and trends related to kidney diseases within accredited Doctor of Pharmacy programs in the United States, using an electronic survey.Responses were received from 61 pharmacy schools, accounting for 43% of ACPE-accredited programs. Instruction on kidney diseases was included in both mandatory and elective courses, while about one-third of schools offered advanced experiential rotations in nephrology. Considerable differences were observed in the duration devoted to kidney disease topics and the types of practical training available. Six institutions reported providing postgraduate education focused on kidney diseases. Most survey participants were clinical faculty with completed residencies and board certifications.Considering the intricate relationship between kidney diseases and other comorbidities, the rising rates of kidney disease, and the evolving role of pharmacists in patient care, it is essential to review current Doctor of Pharmacy curricula to inform future improvements and ensure graduates are prepared for clinical practice.
